The combination of high-dose salvage pelvic radiotherapy and 6 months of androgen-deprivation therapy shows promise for oligorecurrent pelvic nodal relapse of prostatic cancer.
Reuters Health Information
The combination of high-dose salvage pelvic radiotherapy and 6 months of androgen-deprivation therapy shows promise for oligorecurrent pelvic nodal relapse of prostatic cancer.
Reuters Health Information
